Shay Shemesh, Chief Development & Operations Officer at Nuvectis Pharma, Inc. (NVCT), bought 1,278 shares at $16.61 ($20K) on 2022-05-12, disclosed to the SEC on 2022-05-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.58 | 36 | $525 | 2.6% |
| 2 | $15.85 | 1,184 | $19K | 92.7% |
| 3 | $16.61 | 58 | $963 | 4.8% |
| Total | $15.85 avg | 1,278 | $20K | 100% |
| Filing → |
| NVCT | BUY | 2023-03-17 | $7K | — | Filing → |
| NVCT | BUY | 2022-12-22 | $4K | — | Filing → |
| NVCT | BUY | 2022-11-18 | $2K | — | Filing → |